Cilengitide (EMD 121974)
Selleck Chemicals
SKU:S6387-5MG
Couldn't load pickup availability

Cilengitide (EMD 121974) is an inhibitor of Integrins used in studies of target-focused biology. It is especially relevant in angiogenesis and cancer models, where defined compound exposure can be linked to annotated target biology and downstream cellular responses.
By inhibiting Integrins, Cilengitide (EMD 121974) can be used to examine annotated target biology and downstream cellular responses. That positioning is consistent with concentration-response inhibition and target-dependence studies and with follow-up studies that compare concentration-dependent responses across orthogonal assay formats. In angiogenesis and cancer models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Target-focused assays involving Integrins
- Concentration-response inhibition and target-dependence studies
- Phenotypic profiling in angiogenesis and cancer models
- Combination studies with orthogonal perturbagens
Overall, Cilengitide (EMD 121974) is appropriate when a defined chemical perturbant is needed to connect Integrins with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in angiogenesis and cancer models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Targets:
- Integrins
- Target Class:
- Other
- Research Area:
- Angiogenesis • Cancer
- CAS No.:
- 188968-51-6
- Molecular Weight:
- 588.66
- Formula:
- C₂₇H₄₀N₈O₇
- SMILES:
- CC(C)C1N(C)C(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(O)=O)NC(=O)CNC(=O)C(CCCNC(N)=N)NC1=O
- InChIKey:
- AMLYAMJWYAIXIA-UHFFFAOYSA-N
- PubChem:
- 176873
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.